Author's reply

Ophthalmic Physiol Opt. 2021 Nov;41(6):1384. doi: 10.1111/opo.12872. Epub 2021 Aug 17.

Authors

Paul Chamberlain¹, Mark A Bullimore²

Affiliations

¹ CooperVision Inc., Pleasanton, California, USA.
² College of Optometry, University of Houston, Houston, Texas, USA.

PMID: 34402540
DOI: 10.1111/opo.12872

No abstract available

Publication types

Letter
Comment